Company Filing History:
Years Active: 2008
Title: Javier Agejas-Chicharro: Innovator in CNS Disorder Treatments
Introduction
Javier Agejas-Chicharro is a notable inventor based in Alcobendas-Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of central nervous system (CNS) disorders. His innovative work has the potential to impact the lives of many individuals suffering from various mental health conditions.
Latest Patents
Javier holds a patent for Isochroman compounds aimed at treating CNS disorders. This invention relates to compounds of formula (I) where R, W, V, X, Y, p, and n have specific values defined in the claims. These compounds are prepared and utilized as pharmaceuticals for the treatment of conditions such as depression, bipolar disorder, and anxiety. His patent represents a significant advancement in the search for effective treatments for these challenging disorders. He has 1 patent to his name.
Career Highlights
Javier Agejas-Chicharro is currently associated with Eli Lilly and Company, a leading global pharmaceutical company. His work at Eli Lilly focuses on developing innovative solutions for mental health issues, showcasing his commitment to improving patient outcomes through scientific research and development.
Collaborations
Throughout his career, Javier has collaborated with esteemed colleagues, including Graham Henry Timms and Andrew Caerwyn Williams. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking innovations in the pharmaceutical industry.
Conclusion
Javier Agejas-Chicharro is a dedicated inventor whose work in developing Isochroman compounds has the potential to transform the treatment landscape for CNS disorders. His contributions to the field of pharmaceuticals reflect his commitment to advancing mental health care.